InvestorsHub Logo
Followers 523
Posts 6631
Boards Moderated 1
Alias Born 07/24/2012

Re: None

Sunday, 10/28/2012 5:33:13 PM

Sunday, October 28, 2012 5:33:13 PM

Post# of 130503
$AMBS fast forward to 4:13 to listen about what the Company's plans are with their IP(intellectual portfolio) one of them being Manf
I would hold on.....most likely Amarantus will partner with a large Biotech which will benefit us all substantially and then that is only the tip of the iceberg.....They have No intentions on bringing this through FDA approval on their own --but just the rights to the molecular protein is worth 30 million plus ( and that's being conservative)That should put our PPS from .10 to .30!
The news could come out at any time also of a Letter of Intent

http://ih.advfn.com/videos/stock-research/amarantus-biosciences-interviewed-on-the-big-biz-radio-show_nseWcV4uvO8

They own rights to a Protein which reverses CELL DEATH. This Protein (MANF) has Many Many other uses for other diseases in the future but they first started with Parkinson's most Likely b/c of the Michael j. Fox Foundation Funding them in the beginning.